Hepatitis B-surface antigen (HBsAg) vaccine fabricated chitosan-polyethylene glycol nanocomposite (HBsAg-CS-PEG- NC) preparation, immunogenicity, controlled release pattern, biocompatibility or non-target toxicity.
S, Karthick Raja Namasivayam
Hepatitis B-surface antigen (HBsAg) vaccine fabricated chitosan-polyethylene glycol nanocomposite (HBsAg-CS-PEG- NC) preparation, immunogenicity, controlled release pattern, biocompatibility or non-target toxicity. [electronic resource] - International journal of biological macromolecules Feb 2020 - 978-994 p. digital
Publication Type: Journal Article
1879-0003
10.1016/j.ijbiomac.2019.09.175 doi
Animals
Chitosan--chemistry
Delayed-Action Preparations
Drug Carriers--chemistry
Female
Hepatitis B Surface Antigens--immunology
Hepatitis B Vaccines--adverse effects
Male
Materials Testing
Nanocomposites--chemistry
Polyethylene Glycols--chemistry
Rats
Rats, Inbred WF
Rats, Wistar
Hepatitis B-surface antigen (HBsAg) vaccine fabricated chitosan-polyethylene glycol nanocomposite (HBsAg-CS-PEG- NC) preparation, immunogenicity, controlled release pattern, biocompatibility or non-target toxicity. [electronic resource] - International journal of biological macromolecules Feb 2020 - 978-994 p. digital
Publication Type: Journal Article
1879-0003
10.1016/j.ijbiomac.2019.09.175 doi
Animals
Chitosan--chemistry
Delayed-Action Preparations
Drug Carriers--chemistry
Female
Hepatitis B Surface Antigens--immunology
Hepatitis B Vaccines--adverse effects
Male
Materials Testing
Nanocomposites--chemistry
Polyethylene Glycols--chemistry
Rats
Rats, Inbred WF
Rats, Wistar